0.2900
+0.0300
+(11.54%)
At close: January 9 at 7:00:00 PM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Henry Dubina | CEO & Chairman of Board | -- | -- | -- |
| Prof. Jason Hein | CTO & Director | 198.16k | -- | -- |
| Mr. John Kirincic | Chief Financial Officer | -- | -- | -- |
| Dr. Jeffrey W. Sherman Ph.D. | Chief Operating Officer | -- | -- | -- |
| Ms. Deborah Cotter | Company Secretary | -- | -- | -- |
| Shad Grunert | Vice President of Innovation | 4.58k | -- | -- |
Telescope Innovations Corp.
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. The company has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. to develop a method for producing high-purity lithium sulfide. Telescope Innovations Corp. is based in Vancouver, Canada.
Corporate Governance
Telescope Innovations Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
January 28, 2025 at 1:30 PM UTC - February 3, 2025 at 1:30 PM UTC
Telescope Innovations Corp. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
IMC.AX Immuron Limited
0.0820
0.00%
MEM.AX Memphasys Limited
0.0090
-10.00%
GSD.V Devonian Health Group Inc.
0.1650
0.00%
CSBR Champions Oncology, Inc.
9.47
-1.97%
GLOW.CN Glow Lifetech Corp.
0.0600
0.00%
CVALF Covalon Technologies Ltd.
2.2100
-3.07%
NRX.V NurExone Biologic Inc.
0.6800
+4.62%
SEELQ Seelos Therapeutics, Inc.
0.3900
-4.88%
CHRO Channel Therapeutics Corporation
0.9025
-10.64%
VALN Valneva SE
4.5400
-2.37%